Neonatal outcome after IVF

Md A.Sazonova

doi:https://doi.org/10.17116/repro201622265-72

Md A.Sazonova

Reproductive Medicine/IVF Department of Obstetrics and Gynaecology , Sahlgrenska University Hospital, Gothenburg , Sweden, 402 33

Neonatal outcome after IVF

Authors:

Md A.Sazonova

More about the authors

Journal: Russian Journal of Human Reproduction. 2016;22(2): 65‑72

DOI: 10.17116/repro201622265-72

Read: 2749 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Md ASazonova. Neonatal outcome after IVF. Russian Journal of Human Reproduction. 2016;22(2):65‑72. (In Russ.)
https://doi.org/10.17116/repro201622265-72

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Age-related peculiarities of blood parameters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36

The dependence of the ploidic status of embryos on the state of the spindle of oocyte division, assessed using polarization microscopy in IVF programs in women with ovarian endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49

Abstract:

Modern data about neonatal outcomes after IVF are presented.

Keywords:

IVF

neonatal outcomes

Obstetric complications

malformation

Authors:

Md A.Sazonova

Reproductive Medicine/IVF Department of Obstetrics and Gynaecology , Sahlgrenska University Hospital, Gothenburg , Sweden, 402 33

Close metadata

References:

Deligne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation.А review. Human Reproduction. 2002;8:77-96. doi.org/10.1093/humupd/8.6.559.
Korneeva IE, Ivnova AV, Barcalina NV. Ovarian hyperstimulation syndrome: prevention, diagnosis, treatment (literature review). Problems of reproduction. 2004;10:43-50. (In Russ.).
Kodama H, Fukuda J, Karibe H. Status of the coagulation and fibrinolytic system in ovarian hyperstimulation syndrome. Fertility and Sterility. 1996;66:3:417-424. doi.org/10.1016/s0020-7292(97)85624-x.
Rogolino A,Coccia M, Fedi S. Hypercoagulability high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome. Blood Coagulation and Fibrinolysis. 2003;14:3:277-282. doi.org/10.1097/01.mbc.0000061296.28953.d0.
Bitsadze VE, Akinshina SV, Makatsaria AD. Thromboembolic complications associated with the use of assisted reproductive technologies. The ovarian hyperstimulation syndrome. Practical medicine. 2013;7:20-31. (In Russ.).
Protopopova NV, Druzhinina EB. Risk factors and criteria for the prediction of ovarian hyperstimulation syndrome. Newsletter FROM the division of Russian Academy of medical Sciences. 2012;3:65. (In Russ.).
Diagnosis and treatment of ovarian hyperstimulation syndrome. Federal clinical recommendations. Moscow. 2013. (In Russ.).
Intensive care of the ovarian hyperstimulation syndrome. Clinical practice guidelines of the Association of obstetric anaesthesiologists and reanimatologists (treatment protocols). Moscow. 2014. (In Russ.).
Shifman EM, Pogodin OK. Оvarian hyperstimulation syndrome: pathogenetic substantiation of intensive therapy. Anesthesiology and reanimatology. 2007;4:77. (In Russ.).